Syapse, a San Francisco, CA and New York-based evidence company dedicated to advancing real-world care, raised $35M in Growth funding.
The round was led by Innovatus Capital Partners, with participation from existing investors including Ally Bridge Group, Merck Global Health Innovation Fund, Northpond Ventures, Revelation Alpine LLC, Safeguard Scientifics, and Social Capital.
The company intends to use the funds to expand its focus on providing real-world insights to partners and assist them in improving outcomes for people with cancer.
Led by Ken Tarkoff, chief executive officer, Syapse is a company dedicated to extinguishing the fear and burden of oncology and other serious diseases by advancing real-world care. By combining clinical expertise with smart technologies, the company transforms data into evidence—and then into experience—in collaboration with a network of partners, who are committed to improving patients’ lives through community health systems.
Syapse has expanded its Learning Health Network by partnering with some of the nation’s leading community health systems to support precision medicine strategies that are directed at improving clinical outcomes, reducing costs and enhancing the experience of their patients. In addition, the company has added life sciences partnerships with established biopharmaceutical companies.
FinSMEs
27/07/2022